Valneva SE (XBUL:AYJ) FFO


XBUL:AYJ Valneva SE XBUL:AYJ
45 GF Score
Price €2.21
GF Value €2.30
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE FFO?

FFO (Funds from operations) only applies to REITs.

XBUL:AYJ
45GF Score
Valneva SE XBUL:AYJ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Valneva SE (XBUL:AYJ) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of €2.21 is trading 3.9% below its estimated GF Value™ of €2.30. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for XBUL:AYJ:

  • FFO:
  • GF Value™: €2.30 vs. price of €2.21 (3.9% below fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the XBUL:AYJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
45GF Score

Get the complete analysis for XBUL:AYJ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.21
Price
€2.30
GF Value